Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.
Zigler J, Delamarter R, Spivak JM, Linovitz RJ, Danielson GO 3rd, Haider TT, Cammisa F, Zuchermann J, Balderston R, Kitchel S, Foley K, Watkins R, Bradford D, Yue J, Yuan H, Herkowitz H, Geiger D, Bendo J, Peppers T, Sachs B, Girardi F, Kropf M, Goldstein J. Zigler J, et al. Spine (Phila Pa 1976). 2007 May 15;32(11):1155-62; discussion 1163. doi: 10.1097/BRS.0b013e318054e377. Spine (Phila Pa 1976). 2007. PMID: 17495770 Clinical Trial.
Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
Murrey D, Janssen M, Delamarter R, Goldstein J, Zigler J, Tay B, Darden B. Murrey D, et al. Spine J. 2009 Apr;9(4):275-86. doi: 10.1016/j.spinee.2008.05.006. Epub 2008 Sep 6. Spine J. 2009. PMID: 18774751 Clinical Trial.
Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
Delamarter R, Zigler JE, Balderston RA, Cammisa FP, Goldstein JA, Spivak JM. Delamarter R, et al. J Bone Joint Surg Am. 2011 Apr 20;93(8):705-15. doi: 10.2106/JBJS.I.00680. Epub 2011 Mar 11. J Bone Joint Surg Am. 2011. PMID: 21398574 Clinical Trial.
Does 360° lumbar spinal fusion improve long-term clinical outcomes after failure of conservative treatment in patients with functionally disabling single-level degenerative lumbar disc disease? Results of 5-year follow-up in 75 postoperative patients.
Zigler JE, Delamarter RB. Zigler JE, et al. Among authors: delamarter rb. Int J Spine Surg. 2013 Dec 1;7:e1-7. doi: 10.1016/j.ijsp.2013.01.001. eCollection 2013. Int J Spine Surg. 2013. PMID: 25694895 Free PMC article.
ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
Janssen ME, Zigler JE, Spivak JM, Delamarter RB, Darden BV 2nd, Kopjar B. Janssen ME, et al. Among authors: delamarter rb. J Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47. doi: 10.2106/JBJS.N.01186. J Bone Joint Surg Am. 2015. PMID: 26537161 Clinical Trial.
Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease.
Zigler JE, Delamarter RB. Zigler JE, et al. Among authors: delamarter rb. J Neurosurg Spine. 2012 Dec;17(6):493-501. doi: 10.3171/2012.9.SPINE11498. Epub 2012 Oct 19. J Neurosurg Spine. 2012. PMID: 23082846 Clinical Trial.
86 results